跳到主要內容

Graham G. Walmsley 的 Form 4/A 修正申報

修正

Olema Pharmaceuticals, Inc.(OLMA),2024/12/18 申報

申報編號
0000935836-24-000764
申報時間
2024/12/18
交易日
2024/12/13
申報延遲
5 天
10b5-1 計畫
沒有勾選
原始申報日
2024/12/17

這份申報列了 2 筆非衍生性交易。公開市場買進合計 $473.0 萬。公開市場賣出合計 $473.0 萬。交易後 5 天申報。

這份申報後來被修正申報 0000935836-25-000323(2025/5/13)取代,網站的交易表改用修正後的版本。

這份修正申報取代了 0000935836-24-000763(2024/12/17 申報)。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Graham G. WalmsleyCIK 0001777517董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2024/12/13Common StockS賣出處分−700,761$6.75−$4,730,136.750間接
2024/12/13Common StockP買進取得+700,761$6.75+$4,730,136.75700,761間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

The shares are held by Logos Opportunities Fund I LP ("Logos Fund I"). Logos Opportunities GP, LLC ("Logos Opportunities GP") is the general partner of Logos Fund I and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.

F2

The shares are held by Logos Opportunities Fund IV LP ("Logos Fund IV"). Logos Opportunities IV GP LLC ("GP IV") is the general partner of Logos Fund IV and the reporting person is a managing member of GP IV. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.

F3

These securities were sold by Logos Fund I to Logos Fund IV. Logos Fund I and Logos Fund IV are under the common control of the Reporting Person.

F4

The Form 4 filed on December 17, 2024 identified the transaction date as December 17, 2024. The transaction date was December 13, 2024.

F5

The Form 4 filed on December 17, 2024, inadvertently reported the number of shares held by Logos Fund IV after the transaction as 1,408,875. As reported in this amended Form 4, the number of shares held by Logos Fund IV after the transaction is 700,761. The Form 4 also mistakenly reported the purchase of shares by Logos Fund IV as a disposition. The transaction was an acquisition. The transaction date was December 13, 2024.

F6

The shares are held by Logos Opportunities Fund II LP ("Logos Fund II"). Logos Opportunities GP is the general partner of Logos Fund II and the reporting person is a managing member of Logos Opportunities GP. The Form 4 filed on December 17, 2024, incorrectly reported these shares as being held by Logos Fund IV.

看 SEC EDGAR 上的完整原文 (在新分頁開啟)